Technology News and Research

RSS

Health IT Roundup: Digital divide, a VA contract, the open data movement

Computerworld: The digital divide is alive and well when it comes to health care technology. Although President Barack Obama has made it a priority to have medical facilities deploy electronic health records (EHR) over the next four years, the people most likely to benefit -- those in poor and minority communities -- are unlikely to see them anytime soon.

28 Oct 2010

InVivo Therapeutics completes reverse merger with InVivo

InVivo Therapeutics Corporation a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp.

28 Oct 2010

Lotus receives Chinese SFDA approval for R-Bambuterol Hydrochloride Phase I human clinical trials

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it received approval from the State Food and Drug Administration ("SFDA") Ethics Committee to commence Phase I human clinical trials of R-Bambuterol Hydrochloride, the Company's proprietary drug candidate for the treatment of asthma.

28 Oct 2010

IBI receives U.S. patent for novel blood protein biomarkers

Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.

28 Oct 2010

Endologix 2010 third quarter total revenue increases 30% to $17.9 million

Endologix, Inc. developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2010.

28 Oct 2010

BioNanomatrix nanoAnalyzer 1000 System to be introduced at ASHG Annual Meeting

BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, will introduce next month the nanoAnalyzer 1000 System at the American Society of Human Genetics (ASHG) Annual Meeting from November 2-6, 2010 in Washington, D.C.

28 Oct 2010

DIY breast cancer detection kit on its way

In a new discovery a “Do it Yourself” breast cancer detection device has been designed. The device will make breast cancer screening faster, cheaper and more effective. The scanning device is easy and safe to operate it could be installed in GP surgeries or even used at home.

27 Oct 2010

Mastech Holdings 2010 third quarter revenue increases 9.4% to $18.9 million

Mastech Holdings, Inc. a national provider of Information Technology and Specialized Healthcare staffing services, announced today its financial results for the third quarter ended September 30, 2010.

27 Oct 2010

New minimally-invasive approach to traditional facelift procedure

Adam D. Schaffner, M.D., F.A.C.S., Director of Plastic Surgery at JUVA Skin and Laser Center in Manhattan, is challenging the "one size fits all" approach to the traditional facelift with a new, customizable, minimally-invasive and affordable procedure named JuvaLift.

27 Oct 2010

NIH awards $12M over 3 years to promote diversity in scientific workforce

The National Institutes of Health has awarded six grants totaling approximately $12 million over three years through a new initiative aimed at fostering a diverse scientific workforce. The initiative, called the NIH Director's ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce, is funded through the American Recovery and Reinvestment Act (ARRA) and administered by NIH's National Institute of General Medical Sciences.

27 Oct 2010

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

Vical Incorporated today announced that the company's Vice President of Clinical Development, Richard T. Kenney, M.D., is presenting preclinical results from the company's herpes simplex type 2 (HSV-2) vaccine program in a poster session Friday morning at the Keystone Symposium on Immunological Mechanisms of Vaccination (Seattle, October 27 – November 1).

27 Oct 2010

BioSilta releases EnPresso tablet that regulates protein production in recombinant bacteria

BioSilta announces the release of the EnPresso Tablet Cultivation Set, a tabletised form of the patented EnBase technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density.

27 Oct 2010

Scientists develop new imaging technique that can detect breast cancer treatment response

Cancer Research UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today1 (Wednesday).

27 Oct 2010

New campaign raises funds for UCSF Benioff Children's Hospital

UCSF has launched an innovative fundraising campaign that leverages social media to raise awareness of and dollars for UCSF Benioff Children's Hospital. The UCSF Challenge for the Children, a collaboration with the online fundraising platform Causes.com, kicks off today (Oct. 26, 2010) as part of the groundbreaking festivities for the new UCSF Medical Center at Mission Bay, site of the future children's hospital as well as women's and cancer hospitals.

27 Oct 2010

MedAvante's centralized ratings to be used in Rexahn's Serdaxin Phase 2a study in MDD patients

MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings™ in their randomized, double-blind, placebo-controlled Phase 2b clinical study assessing the efficacy of Serdaxin® in patients with major depressive disorder (MDD).

27 Oct 2010

Study finds passive safety engineered devices effective for NSI prevention

A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

From B. Braun Melsungen AG 27 Oct 2010

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.

27 Oct 2010

New International malaria research consortium to develop novel classes of antimalarials

Research teams from three academic institutions and two private sector companies on two continents have come together to form the International malaria research consortium for the development of novel classes of antimalarials. This bold initiative will develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.

27 Oct 2010

New York DOH and NYeC plan to create country's largest network for EHRs

The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.

27 Oct 2010

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

Ferring Pharmaceuticals Inc. presented study results demonstrating that ENDOMETRIN (progesterone) Vaginal Insert provides effective luteal support compared to intramuscular (IM) progesterone-in-oil (PIO) in patients undergoing in vitro fertilization (IVF) using gonadotropin releasing hormone (GnRH) antagonist.

27 Oct 2010

Technology News and Research

Health IT Roundup: Digital divide, a VA contract, the open data movement

InVivo Therapeutics completes reverse merger with InVivo

Lotus receives Chinese SFDA approval for R-Bambuterol Hydrochloride Phase I human clinical trials

IBI receives U.S. patent for novel blood protein biomarkers

Endologix 2010 third quarter total revenue increases 30% to $17.9 million

BioNanomatrix nanoAnalyzer 1000 System to be introduced at ASHG Annual Meeting

DIY breast cancer detection kit on its way

Mastech Holdings 2010 third quarter revenue increases 9.4% to $18.9 million

New minimally-invasive approach to traditional facelift procedure

NIH awards $12M over 3 years to promote diversity in scientific workforce

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

BioSilta releases EnPresso tablet that regulates protein production in recombinant bacteria

Scientists develop new imaging technique that can detect breast cancer treatment response

New campaign raises funds for UCSF Benioff Children's Hospital

MedAvante's centralized ratings to be used in Rexahn's Serdaxin Phase 2a study in MDD patients

Study finds passive safety engineered devices effective for NSI prevention

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

New International malaria research consortium to develop novel classes of antimalarials

New York DOH and NYeC plan to create country's largest network for EHRs

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News